On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, International PublicationsThe evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
/in Dendritic Cells, International PublicationsDendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma
/in Dendritic Cells, International Publications, Soft Tissue SarcomaInduction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
/in Dendritic Cells, Gastric Cancer, International PublicationsAn effective dendritic cell-based vaccine containing glioma stem-like cell lysate and CpG adjuvant for an orthotopic mouse model of glioma
/in Dendritic Cells, Glioblastoma, International PublicationsEffective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International PublicationsImmunotherapy for Triple-Negative Breast Cancer: Latest Research and Clinical Prospects
/in Breast Cancer, Dendritic Cells, International Publications, Newcastle Disease VirusA Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
/in Dendritic Cells, International PublicationsImmunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era?
/in Acute Leukemia, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer